Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    This reflects an update to the site/app revision number for the page display (moving from revision v3.5.2 to v3.5.3), with no indication of any content changes to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T17:09:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:01:49.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The site revision label was updated to v3.5.0 and the previous label v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:21:46.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T20:40:03.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The two screenshots show no detectable differences in the page content. Study design, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-05T18:08:55.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added a Results Posted entry on 2026-02-13 detailing DLT incidence, PFS, adverse events, ORR/OS, and related time frames, and uploaded associated documents (Informed Consent Form, Protocol and SAP).
    Difference
    2%
    Check dated 2026-02-19T05:29:31.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.